Vantage Consulting Group Inc - SPECTRUM PHARMACEUTICALS INC ownership

SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 103 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vantage Consulting Group Inc ownership history of SPECTRUM PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$37,000
-14.0%
29,181
+47.7%
0.01%
+11.1%
Q3 2021$43,000
+10.3%
19,751
+89.7%
0.01%
+28.6%
Q2 2021$39,000
+2.6%
10,414
-10.9%
0.01%
-12.5%
Q1 2021$38,000
+137.5%
11,686
+150.5%
0.01%
+700.0%
Q4 2020$16,0004,6660.00%
Other shareholders
SPECTRUM PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 787,973$615,0000.77%
CM Management, LLC 600,000$468,0000.50%
ARMISTICE CAPITAL, LLC 17,100,000$13,338,0000.23%
Sargent Investment Group, LLC 614,600$479,0000.15%
Ergoteles LLC 744,275$581,0000.02%
Sonora Investment Management Group, LLC 103,000$80,0000.01%
CAXTON ASSOCIATES LP 107,135$84,0000.01%
MCDONALD PARTNERS LLC 42,570$33,0000.01%
Pinz Capital Management, LP 15,600$12,0000.01%
D. E. Shaw & Co., Inc. 8,051,858$6,281,0000.01%
View complete list of SPECTRUM PHARMACEUTICALS INC shareholders